secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001437749-23-011888
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences cancels $65M+ debt via stock issuance to executive chairman at $6.51/share
--------------------------------------------------------------------------------

- Issues 10,022,937 shares to Robert W. Duggan at $6.51 (1%+ premium to $6.44 close) in private placement.
- Cancels $65M principal plus ~$0.25M accrued interest; loan agreement terminates without fees.
- Duggan's beneficial ownership increases from ~62% to ~69% post-closing; no warrants or placement fees.
- Transaction expected to close on or about May 8, 2023, subject to customary conditions.
- CEO says debt elimination strengthens balance sheet for developing nsPFA cardiac devices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923011888/0001437749-23-011888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923011888/plse20230430_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-011888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer